PGEN
Precigen, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Last price
7.18
▼ 0.26 (3.49%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
7.40
Prev close
7.44
Day high
7.50
Day low
7.10
Volume
4.24M
Market cap
$2.58B
P/E (TTM)
—
52W range
2.99 – 7.50
Day trading desk
Gap from prior close
-0.54%
Prior close 7.44
VWAP
7.20
-0.31% from price
Relative volume
0.67×
Normal
Session range
6.76%
7.10 – 7.58
Position in range
17%
Near session low
ATR (14D)
0.45
6.31% of price
Prior day high
7.49
PDH
Prior day low
6.98
PDL
Bid / ask spread
—
Quote not published
Session volume
3.69M
Avg 5.49M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+18.03%
+19.4%
1M
+29.96%
+26.2%
3M
+68.22%
+65.1%
6M
+64.38%
+53.3%
YTD
+72.25%
+60.0%
1Y
+124.30%
+104.3%
3Y
+373.68%
+299.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PGEN open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-3.53M
Net selling
Buy transactions
29
2.26M shares
Sell transactions
12
5.79M shares
Net transactions
+41
Buys less sells
Sell : buy shares
2.6 : 1
Mixed
Insider-held shares
45.35M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 6, 26 | SHAH RUTUL R. Chief Operating Officer |
SELL | 32.74K | $224.59K | Direct |
| Aug 3, 26 | SHAH RUTUL R. Chief Operating Officer |
CONVERSION | 33.77K | $78.69K | Direct |
| Aug 3, 26 | SHAH RUTUL R. Chief Operating Officer |
SELL | 33.77K | $219.52K | Direct |
| Jul 31, 26 | THOMASIAN HARRY JR. Chief Financial Officer |
SELL | 100.00K | $606.00K | Direct |
| Jul 1, 26 | THOMASIAN HARRY JR. Chief Financial Officer |
SELL | 200.00K | $1.11M | Direct |
| Jun 29, 26 | SABZEVARI HELEN Chief Executive Officer |
CONVERSION | 346.84K | $808.13K | Direct |
| Jun 29, 26 | SHAH RUTUL R. Chief Operating Officer |
CONVERSION | 42.92K | $100.01K | Direct |
| Jun 29, 26 | SABZEVARI HELEN Chief Executive Officer |
SELL | 346.84K | $2.04M | Direct |
| Jun 29, 26 | SHAH RUTUL R. Chief Operating Officer |
SELL | 42.92K | $251.10K | Direct |
| May 28, 26 | LEHR DONALD P Officer |
SELL | 29.13K | $127.01K | Direct |
| May 28, 26 | SABZEVARI HELEN Chief Executive Officer |
SELL | 119.25K | $519.93K | Direct |
| May 28, 26 | THOMASIAN HARRY JR. Chief Financial Officer |
SELL | 41.88K | $182.61K | Direct |
| May 28, 26 | SHAH RUTUL R. Chief Operating Officer |
SELL | 42.70K | $186.19K | Direct |
| May 28, 26 | TENNANT PHIL Officer |
SELL | 30.27K | $131.99K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
AGEE NANCY HOWELL |
Director | 305.78K | Conversion of Exercise of derivative security |
ALVAREZ CESAR LICINIO |
Director | 782.91K | Conversion of Exercise of derivative security |
FRANK STEVEN R |
Director | 1.23M | Conversion of Exercise of derivative security |
GUPTA VINITA D |
Director | 666.03K | Conversion of Exercise of derivative security |
HASSAN FRED |
Director | 1.24M | Conversion of Exercise of derivative security |
KIRK RANDAL JOE |
Director and Beneficial Owner of more than 10% of a Class of Security | — | Sale |
LEHR DONALD P |
Officer | 755.46K | Sale |
SABZEVARI HELEN |
Chief Executive Officer | 3.77M | Sale |
SHAH RUTUL R. |
Chief Operating Officer | 465.01K | Sale |
TURLEY JAMES S |
Director | 685.42K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$2.58B
Enterprise value$2.64B
Revenue (TTM)$85.72M
Gross profit$45.44M
EBITDA$-35.36M
Net income$-336.70M
EPS (TTM)$-1.07
Free cash flow$-100.10M
Total cash$38.21M
Total debt$98.34M
Book value / share$0.12
Shares outstanding358.04M
Float194.50M
Short % of float21.54%
Dividend yield—
Beta (5Y)1.01
Valuation & profitability ratios
Trailing P/E—
Forward P/E-32.73
PEG ratio—
Price / sales—
Price / book59.02
EV / revenue30.78
EV / EBITDA-74.61
Gross margin53.01%
Operating margin41.18%
Profit margin-183.98%
Return on equity-837.07%
Return on assets-18.14%
Debt / equity225.69
Current ratio4.58
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $9.68M | $3.92M | $6.22M | $26.91M | +146.7% |
| Operating revenue | $9.68M | $3.92M | $6.22M | $26.66M | +146.7% |
| Cost of revenue | $4.82M | $4.27M | $6.12M | $6.34M | +13.0% |
| Gross profit | $4.86M | -$342.00K | $106.00K | $20.57M | +1,521.3% |
| Research & development | $41.33M | $53.07M | $48.61M | $47.17M | -22.1% |
| Selling, general & admin | $70.13M | $41.29M | $40.41M | $48.01M | +69.8% |
| Total operating expense | $111.46M | $94.36M | $89.03M | $95.18M | +18.1% |
| Operating income | -$106.60M | -$94.70M | -$88.92M | -$74.61M | -12.6% |
| Net interest income | -$652.00K | $1.41M | $2.77M | -$6.64M | -146.2% |
| Pre-tax income | -$250.64M | -$128.03M | -$96.36M | -$79.97M | -95.8% |
| Tax provision | $3.00K | -$1.79M | -$458.00K | -$189.00K | +100.2% |
| Net income | -$250.64M | -$126.23M | -$95.90M | $28.32M | -98.6% |
| Net income to common | -$429.64M | -$126.23M | -$95.90M | $28.32M | -240.4% |
| Basic EPS | -1.37 | -0.47 | -0.39 | 0.14 | -191.5% |
| Diluted EPS | -1.37 | -0.47 | -0.39 | 0.14 | -191.5% |
| EBIT | -$246.77M | -$128.02M | -$95.89M | -$73.19M | -92.8% |
| EBITDA | -$243.57M | -$123.50M | -$89.23M | -$62.43M | -97.2% |
| Basic shares | 312.98M | 267.73M | 244.54M | 200.36M | +16.9% |
| Diluted shares | 312.98M | 267.73M | 244.54M | 200.36M | +16.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $30.23M | $29.52M | $7.58M | $4.86M | — | +2.4% |
| Cash & short-term investments | $97.86M | $97.91M | $62.85M | $55.95M | — | -0.1% |
| Accounts receivable | $3.92M | $926.00K | $902.00K | $978.00K | — | +322.9% |
| Inventory | $9.58M | $0 | — | $287.00K | $326.00K | — |
| Total current assets | $115.23M | $102.41M | $68.75M | $118.16M | — | +12.5% |
| Property, plant & equipment | $18.36M | $18.80M | $14.13M | $15.29M | — | -2.3% |
| Goodwill & intangibles | $18.41M | $23.59M | $67.31M | $81.38M | — | -22.0% |
| Total assets | $155.50M | $145.27M | $151.04M | $215.98M | — | +7.0% |
| Total current liabilities | $37.31M | $21.52M | $22.98M | $78.64M | — | +73.4% |
| Current debt | — | — | — | $43.22M | $52.00K | — |
| Long-term debt | $93.17M | — | — | — | $179.88M | — |
| Total debt | $98.29M | $5.50M | $7.10M | $51.42M | — | +1,686.4% |
| Total liabilities | $134.59M | $106.75M | $32.55M | $89.72M | — | +26.1% |
| Retained earnings | -$2.34B | -$2.09B | -$1.96B | -$1.87B | — | -12.0% |
| Shareholder equity | $20.91M | $38.51M | $118.50M | $126.26M | — | -45.7% |
| Working capital | $77.93M | $80.90M | $45.77M | $39.51M | — | -3.7% |
| Net tangible assets | $2.50M | $14.92M | $51.19M | $44.88M | — | -83.3% |
| Shares issued | 353.91M | 292.87M | 256.40M | 208.15M | — | +20.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$250.64M | -$126.23M | -$95.90M | $28.32M | -98.6% |
| Depreciation & amortisation | $3.20M | $4.53M | $6.67M | $10.77M | -29.3% |
| Stock-based compensation | $10.87M | $9.47M | $9.89M | $10.21M | +14.7% |
| Change in working capital | $7.36M | $4.52M | $17.07M | -$35.70M | +62.7% |
| Operating cash flow | -$87.83M | -$68.17M | -$66.93M | -$65.05M | -28.8% |
| Capital expenditure | -$2.00M | -$8.58M | -$1.54M | -$4.92M | +76.8% |
| Investing cash flow | -$1.53M | -$20.71M | -$3.09M | $226.42M | +92.6% |
| Share buybacks | -$2.20M | $0 | $0 | — | — |
| Financing cash flow | $90.05M | $110.58M | $29.59M | -$155.29M | -18.6% |
| Free cash flow | -$89.83M | -$76.76M | -$68.47M | -$69.97M | -17.0% |
| End cash position | $30.23M | $29.52M | $7.85M | $48.60M | +2.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $54.98M | $23.25M | $4.57M | $2.92M | $856.00K | — | +136.4% |
| Operating revenue | $54.98M | $23.25M | $4.62M | $2.92M | $856.00K | — | +136.4% |
| Cost of revenue | $2.81M | $2.56M | $1.60M | $1.03M | $1.09M | — | +9.6% |
| Gross profit | $52.17M | $20.69M | $2.97M | $1.89M | -$236.00K | — | +152.1% |
| Research & development | $7.28M | $5.64M | $6.99M | $12.38M | $11.49M | — | +29.2% |
| Selling, general & admin | $22.25M | $21.05M | $17.64M | $23.99M | $16.13M | — | +5.7% |
| Total operating expense | $29.53M | $26.69M | $24.64M | $36.37M | $27.62M | — | +10.7% |
| Operating income | $22.64M | -$5.99M | -$21.67M | -$34.48M | -$27.86M | — | +477.7% |
| Net interest income | -$2.59M | -$2.23M | -$1.90M | -$368.00K | $696.00K | — | -16.3% |
| Pre-tax income | $20.07M | -$7.93M | -$23.50M | -$146.34M | -$26.64M | — | +353.1% |
| Tax provision | $0 | $0 | $0 | $0 | $3.00K | — | — |
| Net income | $20.07M | -$7.93M | -$23.50M | -$146.34M | -$26.64M | — | +353.1% |
| Net income to common | $20.07M | -$7.93M | -$23.50M | -$325.34M | -$26.64M | — | +353.1% |
| Basic EPS | 0.06 | -0.02 | — | -1.06 | -0.09 | -0.18 | +400.0% |
| Diluted EPS | 0.05 | -0.02 | — | -1.06 | -0.09 | -0.18 | +350.0% |
| EBIT | $23.02M | -$5.02M | -$20.54M | -$145.44M | -$26.64M | — | +558.6% |
| EBITDA | $24.13M | -$3.92M | -$19.40M | -$144.64M | -$26.01M | — | +715.1% |
| Basic shares | 356.89M | 354.29M | — | 307.17M | 296.43M | 293.88M | +0.7% |
| Diluted shares | 413.69M | 354.29M | — | 307.17M | 296.43M | 293.88M | +16.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $16.33M | $7.48M | $30.23M | $14.32M | $13.76M | — | +118.3% |
| Cash & short-term investments | $38.21M | $56.25M | $97.86M | $121.14M | $59.75M | — | -32.1% |
| Accounts receivable | $71.87M | $26.40M | $3.92M | $580.00K | $327.00K | — | +172.2% |
| Inventory | $20.25M | $14.72M | $9.58M | $3.06M | — | $0 | +37.5% |
| Total current assets | $134.38M | $101.67M | $115.23M | $129.60M | $62.76M | — | +32.2% |
| Property, plant & equipment | $16.87M | $17.52M | $18.36M | $19.59M | $19.43M | — | -3.7% |
| Goodwill & intangibles | $17.78M | $18.10M | $18.41M | $18.73M | $19.05M | — | -1.8% |
| Total assets | $170.30M | $138.63M | $155.50M | $171.26M | $101.90M | — | +22.8% |
| Total current liabilities | $29.35M | $21.10M | $37.31M | $32.07M | $23.19M | — | +39.1% |
| Long-term debt | $93.88M | $93.52M | $93.17M | $92.89M | — | — | +0.4% |
| Total debt | $98.34M | $98.25M | $98.29M | $98.19M | $5.15M | — | +0.1% |
| Total liabilities | $126.72M | $118.39M | $134.59M | $129.40M | $138.68M | — | +7.0% |
| Retained earnings | -$2.33B | -$2.35B | -$2.34B | -$2.32B | -$2.17B | — | +0.9% |
| Shareholder equity | $43.58M | $20.23M | $20.91M | $41.87M | -$36.78M | — | +115.3% |
| Working capital | $105.03M | $80.57M | $77.93M | $97.53M | $39.56M | — | +30.4% |
| Net tangible assets | $25.80M | $2.14M | $2.50M | $23.14M | -$55.83M | — | +1,106.1% |
| Shares issued | 358.01M | 355.90M | 353.91M | 353.81M | 297.85M | — | +0.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $20.07M | -$7.93M | -$23.50M | -$146.34M | -$26.64M | +353.1% |
| Depreciation & amortisation | $1.10M | $1.10M | $1.14M | $803.00K | $630.00K | +0.2% |
| Stock-based compensation | $3.58M | $3.01M | $2.16M | $4.39M | $1.64M | +19.1% |
| Change in working capital | -$42.71M | -$38.03M | -$2.09M | $828.00K | $6.40M | -12.3% |
| Operating cash flow | -$17.81M | -$43.83M | -$23.46M | -$29.07M | -$18.98M | +59.4% |
| Capital expenditure | -$392.00K | -$258.00K | -$18.00K | -$389.00K | -$966.00K | -51.9% |
| Investing cash flow | $26.69M | $20.97M | $39.87M | -$63.39M | $28.44M | +27.3% |
| Share buybacks | $0 | $0 | -$537.00K | -$1.30M | $0 | — |
| Financing cash flow | -$33.00K | $109.00K | -$514.00K | $93.01M | -$1.77M | -130.3% |
| Free cash flow | -$18.20M | -$44.09M | -$23.48M | -$29.46M | -$19.94M | +58.7% |
| End cash position | $16.33M | $7.48M | $30.23M | $14.32M | $13.76M | +118.3% |
Options analytics
Put / call volume
0.10
Call-heavy session
Put / call open interest
0.01
Positioning, not flow
Max pain
5.00
-30.6% from spot
ATM implied vol
90.6%
Nearest strike to spot
Skew (10% OTM)
-14.5%
Calls bid over puts
Call volume
1.21K
Contracts, this expiry
Put volume
115
Contracts, this expiry
Heaviest call OI
8.00
8.30K contracts
Heaviest put OI
7.00
152 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.01 | 0.05 | +475.1% |
| Mar 2026 | -0.04 | -0.02 | +50.0% |
| Dec 2025 | -0.08 | -0.01 | +88.1% |
| Sep 2025 | -0.10 | -1.06 | -1,015.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.08 | 3 | $69.21M | +2,268.6% |
| Next quarter | 0.11 | 3 | $85.53M | +1,773.6% |
| Current year | 0.22 | 3 | $232.97M | +2,305.7% |
| Next year | 0.68 | 3 | $454.38M | +95.0% |
Analyst targets & ownership
Mean target$14.50
High target$18.00
Low target$11.00
Implied upside101.95%
Analyst count2
ConsensusNONE
Strong buy / Buy1 / 1
Hold1
Sell / Strong sell0 / 0
Held by insiders12.67%
Held by institutions72.44%
Institutions holding285
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
6.84
+4.97% from price
SMA 20
6.56
+9.77% from price
SMA 50
5.78
+24.59% from price
SMA 100
4.94
+45.46% from price
SMA 200
4.50
+60.17% from price
EMA 12
6.82
+5.31% from price
EMA 26
6.40
+12.23% from price
EMA 50
5.87
+22.27% from price
RSI (14)
63.4
Neutral
MACD (12,26,9)
0.42
Hist 0.02
ATR (14)
0.45
6.29% of price
Realised vol 30D
63.7%
Annualised
Bollinger upper
7.73
20, 2σ
Bollinger lower
5.38
20, 2σ
50 / 200 cross
Golden
5.78 vs 4.50
Trend bias
Above 200
+60.17%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.48
More volatile than market
Correlation to SPY
0.23
Largely independent
Realised vol 30D
63.7%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-40.5%
Peak to trough
Max drawdown 5Y
-89.3%
Peak to trough
ATR 14
0.45
6.29% of price
Beta (reported)
1.01
5Y monthly, from filing
Short interest
Shares short
42.04M
Prior 44.22M
Change vs prior
-4.9%
Shorts covering
% of float
21.54%
Heavily shorted
% of shares out
11.74%
Against total outstanding
Days to cover
10.4
Crowded exit
Float
194.50M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 5, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Aug 3, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| May 28, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| May 14, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| May 14, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Mar 26, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Mar 26, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Nov 14, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Aug 19, 25 | JMP Securities | MAINTAINED | Market Outperform | Market Outperform |
| Aug 19, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Aug 15, 25 | JP Morgan | UPGRADE | Underweight | Neutral |
| Aug 15, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-04
Corporate Changes & Voting Matters
8-K · 2026-06-24
Periodic Financial Reports
10-Q · 2026-05-13
Proxy Statements
DEF 14A · 2026-04-30
Corporate Changes & Voting Matters
8-K · 2026-03-25
Periodic Financial Reports
10-Q · 2025-11-13
A correspondence can be sent as a document with another submission type or can be sent as a separate submission
CORRESP · 2025-09-17
Corporate Changes & Voting Matters
8-K · 2025-09-03
Headlines
Anika Stock Gains 43.4% in the Past 3 Months: Here Is Why?
Zacks · 2d ago
Reasons Why Investors Should Consider Betting on PGEN Stock
Zacks · 3d ago
Nuvectis Stock Surges Around 97% in 3 Months: Here's Why
Zacks · 4d ago
ARGX Announces Positive Phase III Data on Vyvgart Hytrulo, Stock Up
Zacks · 5d ago
Are You Looking for a Top Momentum Pick? Why Precigen, Inc. (PGEN) is a Great Choice
Zacks · 9d ago
Can Precigen (PGEN) Justify Its Valuation On Earnings And PAPZIMEOS Launch?
Simply Wall St. · 11d ago
Precigen (PGEN) Q2 2026 Earnings Call Transcript
Motley Fool · 12d ago
Precigen, Inc. Q2 2026 Earnings Call Summary
Moby · 18d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.